According to these data, ULK1 may act as an oncogene and tumor suppressor gene and this factor might be a promising target for NSCLC treatment. Bcl2 and LC3 are two more factors which were analyzed in this study. Here, MAP1LC3A is linked to non-small cell lung carcinoma.